Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.
Sorrento Therapeutics, Inc.’s Bankruptcy Court Approves Elective Offering Of Restricted Common Stock Of Scilex Holding Company For Dividend Short Holders
Sorrento Therapeutics, Inc. (OTC:SRNEQ, ", , Sorrento", , )))), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious
